THE OPTIMAL APPROACH TO
RESPIRATORY SYNCYTIAL VIRUS

At LEVIN we have promoted this project in order to identify and analyze the optimal approach to respiratory syncytial virus.

You can download the report by clicking here:

COLLABORATING EXPERT GROUP

This report has been produced through the dialogue and collaboration of a group of experts in pediatrics, neonatology, pharmacology, health economics, health management and scientific research, under the coordination of Dr. Agustín Rivero Cuadrado.

Dr. Agustín Rivero Cuadrado

Project Manager

Director of BioMad, former general director of the Basic Portfolio of the SNS and Pharmacy of the Ministry of Health and former general director of Public Health in the Ministry of Health of the Community of Madrid.

Dra. Cristina Calvo Rey

Head of the Pediatrics, Infectious and Tropical Diseases section of the La Paz University Hospital, president of the Spanish Society of Pediatric Infectious Diseases (SEIP) and Associate Professor of the Alfonso X El Sabio University (UAX).

Dr. Javier Díez-Domingo

Director of the vaccines area of the Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (Fisabio).

Dr. Jorge Mestre-Ferrándiz

Independent economic consultant. Associate Professor at Universidad Carlos III.

Dr. Manuel Sánchez Luna

Head of the Neonatology Service of the Gregorio Marañón University Hospital, president of the Spanish Society of Neonatology and professor of Pediatrics at the Complutense University of Madrid (UCM).

An iniciative of

in collaboration with

*According to data from the Spanish Association of Pediatrics.

THE OPTIMAL APPROACH TO
RESPIRATORY SYNCYTIAL VIRUS

Since the discovery of the Respiratory Syncitial Virus (RSV) in 1956, data have shown that it is the main cause of respiratory infections requiring hospitalization among infants, mainly due to pneumonia and bronchiolitis.

In Spain, it has been estimated that RSV infections cause between 15,000 and 20,000 pediatric emergency visits each year and 7,000 to 14,000 hopitalizations . The number of children who die from infections caused by this virus is between 70 and 250 per year .

In this regard, and taking into account the parameters of frecuency, lethality, cost and speed of expansion indicated by the World Health Organization (WHO), RSV could be considered a public health problem.

At LEVIN we have promoted this project in order to identify and analyze the optimal approach to respiratory syncytial virus.

Its development has resulted in a detailed report that identifies the challenges and areas for improvement that will help us face the challenge posed by this pathology for the National Health System, health professionals and patients who suffer from it.

You can download the report by clicking here:

COLLABORATING EXPERT GROUP

This report has been produced through the dialogue and collaboration of a group of experts in pediatrics, neonatology, pharmacology, health economics, health management and scientific research, under the coordination of Dr. Agustín Rivero Cuadrado.

Dr. Agustín Rivero Cuadrado

Dra. Cristina Calvo Rey

Dr. Javier Díez-Domingo

Dr. Jorge Mestre-Ferrándiz

Dr. Manuel Sánchez Luna

An iniciative of

in collaboration with

Since the discovery of the Respiratory Syncitial Virus (RSV) in 1956, data have shown that it is the main cause of respiratory infections requiring hospitalization among infants, mainly due to pneumonia and bronchiolitis.

In Spain, it has been estimated that RSV infections cause between 15,000 and 20,000 pediatric emergency visits each year and 7,000 to 14,000 hopitalizations *. The number of children who die from infections caused by this virus is between 70 and 250 per year *.

In this regard, and taking into account the parameters of frecuency, lethality, cost and speed of expansion indicated by the World Health Organization (WHO), RSV could be considered a public health problem.

Its development has resulted in a detailed report that identifies the challenges and areas for improvement that will help us face the challenge posed by this pathology for the National Health System, health professionals and patients who suffer from it.

You can download the report by clicking here:

This report has been produced through the dialogue and collaboration of a group of experts in pediatrics, neonatology, pharmacology, health economics, health management and scientific research, under the coordination of Dr. Agustín Rivero Cuadrado.

Dr. Agustín Rivero Cuadrado

Dra. Cristina Calvo Rey

Dr. Javier Díez-Domingo

Dr. Jorge Mestre-Ferrándiz

Dr. Manuel Sánchez Luna

An iniciative of ​

in collaboration with

In Spain, it has been estimated that RSV infections cause between 15,000 and 20,000 pediatric emergency visits each year and 7,000 to 14,000 hopitalizations . The number of children who die from infections caused by this virus is between 70 and 250 per year .

An iniciative of